Vnitr Lek 2026, 72(1):38-42 | DOI: 10.36290/vnl.2026.005

Arterial hypertension is an important topic even in patients admitted to hospitals for other reasons

Pavel Rutar
Interní oddělení Fakultní nemocnice Motol a Homolka, Praha

Arterial hypertension affects nearly 20% of Czech population. Due to this high prevalence, arterial hypertension has become a diagnosis seen on daily basis by general practitioners in primary care as well by specialists in hospitals. Despite the amount of energy and time which doctors give into the treatment of hypertension, we can still find patients who are not treated in the best way. And because we can still find some space for improvement, we should take care about the treatment of hypertension even at patients who came to the hospital for other reasons. Hospitalisation on its own brings very good conditions for frequent blood pressure controls and for review of chronic pharmacotherapy.

Keywords: arterial hypertension, fix combinations, hypertension mediated organ damage, cardiovascular risk, medication adherence, therapeutical inertia.

Accepted: February 3, 2026; Published: February 12, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Rutar P. Arterial hypertension is an important topic even in patients admitted to hospitals for other reasons. Vnitr Lek. 2026;72(1):38-42. doi: 10.36290/vnl.2026.005.
Download citation

References

  1. Ústav zdravotnických informací a statistiky ČR. Národní registr hrazených zdravotních služeb (NRHZS) 2010-2023.
  2. Vasan RS, Song RJ, Xanthakis V, et al. Hypertension-Mediated Organ Damage: Prevalence, Correlates, and Prognosis in the Community. Hypertension. 2022;79:505-515. Go to original source... Go to PubMed...
  3. Rahimi K, Bidel Z, Nazarzadeh M, et al. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis. Lancet. 2021;397(10285):1625-1636. Go to original source... Go to PubMed...
  4. Du LP, Cheng ZW, Zhang YX, et al. The impact of fixed-dose combination versus free-equivalent combination therapies on adherence for hypertension: a meta-analysis. J Clin Hypertens (Greenwich). 2018;20(5):902-907. Go to original source... Go to PubMed...
  5. Simons LA, Chung E, Ortiz M, et al. Long-term persistence with single-pill, fixed-dose combination therapy versus two pills of amlodipine and perindopril for hypertension: Australian experience. Curr Med Res Opin. 2017;33(10):1783-1787. Go to original source... Go to PubMed...
  6. Dušek L. Národní informační kardiologický systém. O co přicházíme, když neléčíme důsledně. Prezentace z XXXII. výročního sjezdu České kardiologické společnosti, Brno, 4.-7. 5. 2024.
  7. McEvoy JW, McCarthy CP, Bruno RM, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024;45(38):3912-4018. Go to original source... Go to PubMed...
  8. Státní ústav pro kontrolu léčiv. Souhrn údajů o přípravku: Penicilin G draselná sůl BBP 1 MIU prášek pro injekční/infuzní roztok [Internet]. Praha: SÚKL. Available from: https://sukl.cz
  9. Státní ústav pro kontrolu léčiv. Souhrn údajů o přípravku: Kalium chloratum Biomedica tbl. ent., 500 mg, enterosolventní tablety [Internet]. Praha: SÚKL. Available from: https://sukl.cz
  10. Svačina Š. Hypertenze při obezitě a diabetu. Praha: Triton; 2007. 136 s.
  11. Prokopová I. Účinná a bezpečná terapie arteriální hypertenze u obézního pacienta s metabolickým syndromem. Prakt Lékáren. 2016;12(5):176-181. Go to original source...
  12. Widimský J, Filipovský J, Ceral J, et al. Doporučení ČSH 2022. Hypertenze a KV prevence. 2022;12:1-25.
  13. Karpov YA, FORTISSIMO physicians. Full-dose Perindopril/Indapamide in the Treatment of Difficult to Control Hypertension: The FORTISSIMO Study. Clin Drug Investig. 2017;37(2):207-217. Go to original source... Go to PubMed...
  14. Patel A, MacMahon S, Chalmers J, et al.; ADVANCE Collaborative Group. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet. 2007;370(9590):829-840. Go to original source... Go to PubMed...
  15. Chalmers J, Mourad JJ, Brzozowska-Villatte R, et al. Benefit of treatment based on indapamide mostly combined with perindopril on mortality and cardiovascular outcomes: a pooled analysis of four trials. J Hypertens. 2023;41(3):508-515. Go to original source... Go to PubMed...
  16. Dalia A. Therapeutic inertia in the management of hypertension in primary care. J Hypertens. 2021;39(6):1238-1245. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.